Important Update: Dr. Aaron Rollins is no longer the CEO of AirSculpt Technologies. He stepped down as CEO in January 2023 and served as Executive Chairman of the Board until his resignation from the board in November 2025. Yogi Jashnani was appointed CEO effective January 7, 2025. This page is preserved for historical reference. Dr. Rollins remains the founder and inventor of the AirSculpt procedure.
Dr. Aaron Rollins is the founder of AirSculpt Technologies, Inc. (NASDAQ: AIRS), the company behind the patented, minimally invasive fat removal procedure performed exclusively at Elite Body Sculpture locations. Dr. Rollins founded the company in 2012 and served as CEO until January 2023, then as Executive Chairman until November 2025. A board-certified cosmetic surgeon based in Beverly Hills, he revolutionized body contouring by creating a technology that removes fat cell by cell through a tiny entry point — without a scalpel, needle, stitches, or general anesthesia. He took AirSculpt public on NASDAQ in October 2021 and built it into a 30+ location nationwide practice before stepping back from operations.
(Suggested: Alignment Healthcare CEO Email & Net Worth – John Kao)

AirSculpt Competitors
AirSculpt Technologies operates in the competitive body contouring and cosmetic procedures industry. Key competitors of AirSculpt include:
- Sono Bello – largest national provider of laser liposuction and body contouring (100+ locations)
- CoolSculpting (AbbVie/Allergan) – non-invasive cryolipolysis fat freezing technology
- Ideal Image – medical aesthetics chain offering laser hair removal and body contouring (170+ locations)
- SmartLipo / Cynosure – laser-assisted liposuction technology used at independent clinics
- Traditional Plastic Surgery Clinics – thousands of independent practices performing standard liposuction and tummy tucks
- SculpSure (Cynosure) – non-invasive laser body contouring
- VASER Lipo (Solta Medical) – ultrasound-assisted liposuction technology
Dr. Aaron Rollins – Quick Facts
Dr. Aaron Rollins Net Worth 2026 – AirSculpt CEO Salary
As of 2026, Dr. Aaron Rollins’ net worth is estimated at approximately $30–60 million USD. This estimate is based on his disclosed ownership stake of roughly 15.1 million shares of AirSculpt Technologies (AIRS) stock, valued at approximately $28–30 million at current trading prices (~$1.88/share), plus additional personal assets, surgical practice income, and prior cash compensation. At the time of AirSculpt’s October 2021 IPO, when shares traded near $16, Rollins’ stake alone was worth over $240 million, but the stock has declined more than 88% since then.
Dr. Aaron Rollins Compensation Breakdown (FY2023)
AirSculpt Technologies Net Worth 2026 – Is AirSculpt Profitable?
No, AirSculpt Technologies is not currently profitable. The company reported a net loss of $8.3 million in fiscal year 2024, widening from a $4.5 million loss in 2023. Revenue declined 7.9% to $180.4 million as case volumes fell and the company paused new center openings to focus on operational efficiency. Under new CEO Yogi Jashnani (appointed January 2025), the company has initiated a cost reduction program expected to save approximately $3 million annually.
AirSculpt Technologies Financial Summary (FY2024)
(Recommended: LifeStance Health CEO Email & Net Worth – Dave Bourdon)
AirSculpt CEO Email Address | Dr. Aaron Rollins Contact
Below are the contact details and social media profiles associated with AirSculpt founder Dr. Aaron Rollins. Note that Dr. Rollins resigned from the board in November 2025 and may no longer be reachable at the corporate email.
Career & Education – Company, University, & College
Dr. Aaron Rollins built his career at the intersection of medicine and art. A lifelong sculptor and art enthusiast, he channeled his creative instincts into plastic surgery, seeking to develop less invasive and more precise body contouring techniques. After years of performing traditional cosmetic surgery procedures, he became convinced there had to be a better approach — one that would reduce pain, downtime, and scarring while producing superior results.
Dr. Aaron Rollins Career Timeline
Dr. Rollins founded Elite Body Sculpture in 2012 in Beverly Hills after years of research into less invasive fat removal techniques. Based on patient feedback and his own artistic sensibilities, he invented the AirSculpt procedure — a patented technology that uses a spinning, vibrating cannula to gently dislodge and extract fat cells one at a time through an entry point the size of a freckle. Unlike traditional liposuction, it requires no scalpel, no needle, no stitches, and no general anesthesia.
Under his leadership as CEO, Elite Body Sculpture expanded from a single Beverly Hills location to over 25 centers across the United States. He took the company public on NASDAQ in October 2021 under the ticker AIRS. In January 2023, Dr. Rollins transitioned from CEO to Executive Chairman, with Todd Magazine briefly serving as interim CEO before Yogi Jashnani was appointed CEO in January 2025.
(Related: Privia Health CEO Email & Net Worth – Parth Mehrotra)
Education
Dr. Rollins completed his undergraduate studies and medical degree at McGill University in Montreal, Canada, graduating with “Great Distinction” in 2001. He completed a transitional year internship at the Icahn School of Medicine at Mount Sinai (Morningside) in New York (2002–2003), followed by surgical training at the University of California, San Francisco (2005–2006). He is a diplomate of the American Board of Laser Surgery and an affiliate member of the American College of Surgeons.
Dr. Aaron Rollins Wiki – Age, Family, & More
AirSculpt founder Dr. Aaron Rollins is approximately 51 years old as of 2026 (estimated based on his 2001 medical school graduation). He is based in the Beverly Hills / Los Angeles, California area. Before settling in Southern California, Dr. Rollins lived on rental properties in New York, Houston, and Sacramento during his medical training years. He is known for keeping his personal and family life private.
Notable Achievements & Recognitions
- AirSculpt Inventor – Created the patented AirSculpt body contouring technology, a first-of-its-kind minimally invasive fat removal procedure
- I.D.E.A. Bronze Medal – Awarded the International Design Excellence Award for medical inventions
- McGill “Great Distinction” – Graduated medical school with the university’s highest academic honor
- NASDAQ IPO – Led AirSculpt Technologies to a successful public listing in October 2021, valued at ~$941 million
- Compassionate Doctor Certification – Recognized for patient-centered care and follow-up practices
- Media Appearances – Featured on Extra, Good Day LA, and Good Morning America as a cosmetic surgery expert
Dr. Rollins has always described himself as an artist first and a surgeon second, combining his lifelong love of sculpture with his medical training. He has said: “Everyone’s unique and to get the best possible results, you treat people as such.” His AirSculpt technology pioneered procedures like the Hip Flip and Up-A-Cup (natural breast augmentation using a patient’s own transferred fat).
(Suggested: HCA Healthcare CEO Email & Net Worth – Sam Hazen)
About AirSculpt Technologies
AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a body contouring technology company headquartered in Miami Beach, Florida. Founded in 2012 by Dr. Aaron Rollins, the company operates under the consumer brand Elite Body Sculpture and provides its proprietary AirSculpt procedure — a minimally invasive fat removal and body sculpting treatment that requires no scalpel, needle, stitches, or general anesthesia. The technology removes fat cell by cell through a small entry point, enabling procedures such as liposuction alternatives, Brazilian butt lifts, natural breast augmentation (Up-A-Cup), and chin sculpting.
AirSculpt Technologies went public on NASDAQ in October 2021 under the ticker symbol AIRS. The company operates over 31 Elite Body Sculpture centers across the United States, Canada, and the United Kingdom, employing approximately 422 people. As of early 2026, the company has a medium-term goal of operating more than 100 centers.
Frequently Asked Questions (FAQ)
Is Dr. Aaron Rollins still the CEO of AirSculpt?
No. Dr. Aaron Rollins stepped down as CEO in January 2023 and served as Executive Chairman of the Board until November 2025, when he resigned from the board entirely. Yogi Jashnani was appointed CEO effective January 7, 2025. Dr. Rollins remains the founder and inventor of the AirSculpt technology.
What is Dr. Aaron Rollins’ net worth in 2026?
As of 2026, Dr. Aaron Rollins’ net worth is estimated at approximately $30–60 million USD, based on his disclosed ownership of roughly 15.1 million shares of AIRS stock (valued at ~$28–30 million at current prices) plus personal assets and prior compensation. His stake was worth over $240 million at the 2021 IPO peak.
What was AirSculpt CEO’s salary?
In his final full year as Executive Chairman (FY2023), Dr. Aaron Rollins earned total compensation of approximately $3.7 million, including an $875,000 base salary, $638,750 in performance bonuses, equity awards worth ~$1.75 million, and $207,750 in surgical service fees.
What is AirSculpt CEO’s email address?
Dr. Aaron Rollins’ email was [email protected]. For current company inquiries, contact AirSculpt Technologies via their website at airsculpt.com or their headquarters in Miami Beach, Florida.
Where did Dr. Aaron Rollins go to medical school?
Dr. Aaron Rollins attended McGill University Faculty of Medicine in Montreal, Canada, graduating with “Great Distinction” in 2001. He completed his undergraduate studies at McGill University as well. He later trained at the Icahn School of Medicine at Mount Sinai and the University of California, San Francisco.
Is AirSculpt Technologies profitable?
No, AirSculpt Technologies reported a net loss of $8.3 million in fiscal year 2024, on revenue of $180.4 million (down 7.9% year-over-year). The company has been operating at a loss since 2023 and has initiated cost reduction measures under its new CEO Yogi Jashnani.
Article last updated:January 2026March 2, 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings (DEF 14A proxy statements, 8-K filings), official company press releases, and reputable news outlets. Net worth figures are estimates based on disclosed stock holdings and may vary. This content is provided for informational purposes only and does not constitute financial or investment advice.